[HTML][HTML] The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology

A Kawakami, DE Fisher - Laboratory investigation, 2017 - Elsevier
Certain transcription factors have vital roles in lineage development, including specification
of cell types and control of differentiation. Microphthalmia-associated transcription factor …

MITF in melanoma: mechanisms behind its expression and activity

ML Hartman, M Czyz - Cellular and Molecular Life Sciences, 2015 - Springer
MITF (microphthalmia-associated transcription factor) represents a melanocytic lineage-
specific transcription factor whose role is profoundly extended in malignant melanoma. Over …

Potential therapeutic targets of epithelial–mesenchymal transition in melanoma

RL Pearlman, MKM de Oca, HC Pal, F Afaq - Cancer letters, 2017 - Elsevier
Melanoma is a cutaneous neoplastic growth of melanocytes with great potential to invade
and metastasize, especially when not treated early and effectively. Epithelial-mesenchymal …

Role of miRNAs in melanoma metastasis

A Gajos-Michniewicz, M Czyz - Cancers, 2019 - mdpi.com
Tumour metastasis is a multistep process. Melanoma is a highly aggressive cancer and
metastasis accounts for the majority of patient deaths. microRNAs (miRNAs) are non-coding …

[HTML][HTML] Pro-survival role of MITF in melanoma

ML Hartman, M Czyz - Journal of Investigative Dermatology, 2015 - Elsevier
Melanoma is a therapy-resistant skin cancer due to numerous mechanisms supporting cell
survival. Although components of melanoma cytoprotective mechanisms are overexpressed …

The slow cycling phenotype: a growing problem for treatment resistance in melanoma

A Ahn, A Chatterjee, MR Eccles - Molecular cancer therapeutics, 2017 - AACR
Abstract Treatment resistance in metastatic melanoma is a longstanding issue. Current
targeted therapy regimes in melanoma largely target the proliferating cancer population …

MITF deficiency accelerates GNAQ-driven uveal melanoma

GB Phelps, HR Hagen… - Proceedings of the …, 2022 - National Acad Sciences
Cutaneous melanoma (CM) and uveal melanoma (UM) both originate from the melanocytic
lineage but are primarily driven by distinct oncogenic drivers, BRAF/NRAS or GNAQ/GNA11 …

BRN 2, a POU erful driver of melanoma phenotype switching and metastasis

ME Fane, Y Chhabra, AG Smith… - Pigment Cell & …, 2019 - Wiley Online Library
The POU domain family of transcription factors play a central role in embryogenesis and are
highly expressed in neural crest cells and the developing brain. BRN 2 is a class III POU …

MITF and BRN2 contribute to metastatic growth after dissemination of melanoma

JL Simmons, CJ Pierce, F Al-Ejeh, GM Boyle - Scientific reports, 2017 - nature.com
Melanoma tumors are highly heterogeneous, comprising of different cell types that vary in
their potential for growth and invasion. Heterogeneous expression of the Microphthalmia …

Understanding molecular mechanisms of phenotype switching and crosstalk with TME to reveal new vulnerabilities of melanoma

A Najem, L Soumoy, M Sabbah, M Krayem, A Awada… - Cells, 2022 - mdpi.com
Melanoma cells are notorious for their high plasticity and ability to switch back and forth
between various melanoma cell states, enabling the adaptation to sub-optimal conditions …